Cell biology of aminoglycoside nephrotoxicity: Newer aspects

Current Opinion in Nephrology and Hypertension

Volumn 6, Issue 4, 1997, Pages 384-388

  Molitoris, Bruce A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT;

ADAPTATION; CELLULAR DISTRIBUTION; CYTOLOGY; ENDOCYTOSIS; GOLGI COMPLEX; HUMAN; INTERNALIZATION; KIDNEY PROXIMAL TUBULE; LIGAND BINDING; MEMBRANE BINDING; NEPHROTOXICITY; PRIORITY JOURNAL; REVIEW; UREMIA;

EID: 0030745876     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199707000-00013     Document Type: Review

References (22)

1. Zager RA: Gentamicin nephrotoxicity in the setting of acute renal hypoperfusion. Am J Physiol 1988, 254:F574-F581
2. Spiegel DM, Shanley PF, Molitoris BA: Mild ischemia predisposes the S3 segment of the proximal tubule to acute gentamicin toxicity. Kidney Int 1990, 38:459-464.
3. Molitoris BA, Meyer C, Dahl R, Geerdes A: Mechanism of ischemia-enhanced aminoglycoside binding and uptake by proximal tubule cells. Am J Physiol 1993, 264:F907-F916.
4. Christensen EI, Nielsen S: Structural and functional features of protein handling in the kidney proximal tubule. Semin Nephrol 1991, 11:414-439.
5. Ford DM, Dahl RH, Lamp CA, Molitoris BA: Apically and basolaterally internalized aminoglycosides co-localize in LLC-PK1 lysosomes and alter cell function. Am J Physiol 1994, 266:C52-C57.
6. 1 cells. Am J Physiol 1995, 268:F829-F838.
7. Schentag JJ, Plaut ME, Cerra FB: Comparative nephro-toxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients. Antimicrob Agents Chemother 1981, 19:859.
8. Kishore BK, Lambricht IP, Laurent B, Maldague P, Tulkens PM: Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats. Pharmacol Exp Ther 1992, 262:424.
9. Bennett WM, Mela-Riker LM, Houghton DC, Gilbert DN, Buss WC: Microsomal protein synthesis inhibition: an early manifestation of gentamicin nephrotoxicity. Am J Physiol 1988, 255:F265.
10. Moestrup SK, Christensen EI, Nielsen S, Jorgensen KE, Bjorn SE, Roigaard H, Gliemann J: Binding and endocytosis of proteins mediated by epithelial gp330. Ann NY Acad Sci 1994, 737:20-38.
11. Kounnas MZ, Loukinova EB, Stefansson S, Harmony JAK, Brewer BH, Strickland DK, Argraves WS: Identification of glycoprotein 330 as an endocytic receptor for apolipoprotein J/clusterin. J Biol Chem 1995, 270:13070-13075.
12. Christensen EI, Nielsen S, Moestrup SK, Borre C, Maunsbach AB, De Heer E, Ronco P, Hammond TG, Verroust P: Segmental distribution Of the endocytosis receptor gp330 in renal proximal tubules. Eur J Cell Biol 1995, 66:349-364.
13. Moestrup SK, Shiying C, Vorum H, Bregengard C, Bjorn SE, Norris K, Gliemann J, Christensen EI: Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. J Clin Invest 1995, 96:1404.
14. Cui S, Verroust Pj, Moestrup Sk, Christensen EI: Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am J Physiol 1996, 271:F900-F907.
15. Czekay RP, Orlando RA, Woodward L, Lundstrom M, Farquhar MG: Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes. Mol Biol Cell 1997, 8:517-532
16. Hammond TG, Majewski RR, Kaysen JH, Goda FO, Navar GI, Pontillon F, Verroust PJ: Gentamicin inhibits rat renal cortical homotypic endosomal fusion: role of megalin. Am J Physiol 1997, 272:F117-F123. This was the first demonstration that an aminoglycoside could inhibit endosomal fusion. Also, the potential role of megalin in mediating this altered fusion was addressed.
17. Sandoval R, Molitoris BA: Intracellular trafficking of gentamicin: endoplasmic reticulum (ER) and Golgi associations [Abstract]. J Am Soc Nephrol 1995, 6:1003.
18. Goda Y, Soldati T, Pfeffer SR: Transport from late endosomes to trans-Golgi network in semi-intact cell extracts. Methods Enzym 1992, 219:153.
19. Riederer MA, Soldati T, Shapiro AD, Lin J, Pfeffer SR: Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J Cell Biol 1994, 125:573.
20. Sandvig K, Ryd M, Oystern G, Schweda E, Holm PK, Van Deurs B: Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga β-fragment is regulated by butyric acid and cAMP. J Cell Biol 1994, 126:53-64.
21. Sandvig K, Garred O, Van Helvoort A, Van Meer G, Van Duers B: Importance of glycolipid synthesis for butyric acid-induced sensitization to Shiga toxin and intracellular sorting of toxin in A431 cells. Mol Biol Cell 1996, 7:1391-1404.
22. Sundin DP, Meyer C, Dahl R, Geerdes A, Sandoval R, Molitoris BA: Cellular mechanism of aminoglycoside tolerance in long-term gentamicin treatment. Am J Physiol (In press). The authors showed that continued administration of gentamicin induced a selective decrease in apical gentamicin endocytosis that was independent of changes in megalin levels or distribution and surface membrane binding.